BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20164033)

  • 1. Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Chwiecko J; Skowronski J; Sierakowski S; Chyczewski L; Kowal-Bielecka O
    Folia Histochem Cytobiol; 2009 Jan; 47(3):465-9. PubMed ID: 20164033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.
    Bielecki M; Kowal K; Lapinska A; Chwiesko-Minarowska S; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2011; 56(2):255-63. PubMed ID: 21983449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
    Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
    Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased production of a proliferation-inducing ligand (APRIL) by peripheral blood mononuclear cells is associated with antitopoisomerase I antibody and more severe disease in systemic sclerosis.
    Bielecki M; Kowal K; Lapinska A; Bernatowicz P; Chyczewski L; Kowal-Bielecka O
    J Rheumatol; 2010 Nov; 37(11):2286-9. PubMed ID: 20810514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis.
    Yamamoto T; Sawada Y; Katayama I; Nishioka K
    Br J Rheumatol; 1998 Oct; 37(10):1123-5. PubMed ID: 9825753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Ihn H; Takehara K
    Rheumatology (Oxford); 1999 Jul; 38(7):612-7. PubMed ID: 10461473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
    Andrigueti FV; Arismendi MI; Ebbing PC; Kayser C
    Microvasc Res; 2015 Mar; 98():82-7. PubMed ID: 25596148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
    Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis.
    Gruschwitz MS; Albrecht M; Vieth G; Haustein UF
    J Rheumatol; 1997 Oct; 24(10):1936-43. PubMed ID: 9330935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macro- and microvascular disease in systemic sclerosis.
    Kavian N; Batteux F
    Vascul Pharmacol; 2015 Aug; 71():16-23. PubMed ID: 26044180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capillaroscopic findings in systemic sclerosis -- are they associated with disease duration and presence of digital ulcers?
    Lambova S; Müller-Ladner U
    Discov Med; 2011 Nov; 12(66):413-8. PubMed ID: 22127112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.